Hulk Hogan's cause of death was a heart attack, medical examiner says
Hogan, 71, whose real name was Terry Bollea, previously had leukaemia and atrial fibrillation, an irregular heart rhythm, the report from the District Six Medical Examiner said.
To honour the 'Hulkster', governor of Florida Ron DeSantis said, flags will be flown at half-staff at all official buildings Friday, which he declared 'Hulk Hogan Day in Florida'.
'He was a true Floridian through and through,' the Republican governor wrote in a memo Thursday.
Hogan was pronounced dead at a hospital less than 90 minutes after medics arrived at his home in Clearwater to answer a call about a cardiac arrest on the morning of Jul 24, police said. The report said the cause of death was "natural".
'He had been dealing with some health issues, but I truly believed we would overcome them,' Hogan's wife Sky Daily posted on Instagram.
'This loss is sudden and impossible to process,' she added. 'To the world, he was a legend… but to me, he was my Terry.'
Hogan was perhaps the biggest star in WWE's long history, known for both his larger-than-life personality and his in-ring exploits. He was the main draw for the first WrestleMania in 1985 and was a fixture for years, facing everyone from Andre The Giant and Randy Savage to The Rock and even WWE co-founder Vince McMahon.
Hogan's daughter Brooke Bollea Oleksy, better known by her stage name Brooke Hogan, memorialised her father in a recent social media post.
'I am so grateful I knew the real version of him. Not just the one the world viewed through a carefully curated lens,' she wrote on Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNA
a day ago
- CNA
US axes mRNA vaccine contracts, casting safety doubts
WASHINGTON: President Donald Trump's administration on Tuesday (Aug 5) announced it would terminate 22 federal contracts for mRNA-based vaccines, questioning the safety of a technology credited with helping end the COVID-19 pandemic and saving millions of lives. The announcement, made by Health Secretary Robert F Kennedy Jr, marks his latest effort to weave vaccine skepticism into the core of US government policy. "We reviewed the science, listened to the experts, and acted," Kennedy said in a statement. The health department's Biomedical Advanced Research and Development Authority (BARDA) is "terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu", he added. "We're shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate." The changes affect Moderna's mRNA bird flu vaccine - a move the company itself disclosed in May - as well as numerous other programmes, including "rejection or cancellation of multiple pre-award solicitations" from pharmaceutical giants Pfizer and Sanofi. In total, the affected projects are worth "nearly US$500 million," the Department of Health and Human Services (HHS) said. Certain late-stage projects were excluded from the move "to preserve prior taxpayer investment." "Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them," Secretary Kennedy said. "That's why we're moving beyond the limitations of mRNA and investing in better solutions." Since taking office, Kennedy, who spent two decades sowing misinformation around immunisation, has overseen a major overhaul of US health policy - firing, for example, a panel of vaccine experts that advise the government and replacing them with his own appointees. In its first meeting, the new panel promptly voted to ban a longstanding vaccine preservative targeted by the anti-vaccine movement, despite its strong safety record. He has also ordered a sweeping new study on the long-debunked link between vaccines and autism. Unlike traditional vaccines, which often use weakened or inactivated forms of the target virus or bacteria, mRNA shots deliver genetic instructions into the host's cells, prompting them to produce a harmless decoy of the pathogen and train the immune system to fight the real thing. Though in development for decades, mRNA vaccines were propelled from lab benches to widespread use through President Trump's Operation Warp Speed - a public-private partnership led by BARDA that poured billions into companies to accelerate development. The technology's pioneers, Katalin Kariko and Drew Weissman, were awarded the 2023 Nobel Prize in Medicine for their work contributing "to the unprecedented rate of vaccine development during one of the greatest threats to human health in modern times."
CNA
a day ago
- CNA
Former X CEO Yaccarino takes helm at GLP-1 focused telehealth firm eMed
Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, nearly a month after stepping down as CEO of social media platform X. Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive its reputation among advertisers, who were wary of the platform's content as well as the billionaire's steady stream of controversial posts. Although devoid of any experience in the health sector, she does bring in deep expertise in brand partnerships and digital revenue growth. At NBCUniversal, she modernized the global advertising business over a decade. At X, she helped regain advertiser confidence following turbulence under Musk's ownership. In her first public statement following her appointment, Yaccarino said, "There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before." Gil Luria, an analyst at D.A. Davidson, said Yaccarino brings critical experience in consumer-focused digital platforms. "This new category of apps like Hims and LifeMD are mostly focused on the consumer Ms. Yaccarino's experience is in media, much of that has had to do with creating consumer engagement." Miami, Florida-based eMed, founded in 2020, partners with employers and government payers to manage GLP-1 usage, a class of obesity and diabetes drugs whose cost burden has been a barrier to a wider insurance coverage. The company claims its platform can cut costs of a weight loss program by up to 50 per cent, offering live, on-demand care without appointments. EMed gained traction during the pandemic with at-home COVID-19 tests and later expanded into diagnostics for strep throat and UTIs, though it has since moved away from those offerings.
CNA
a day ago
- CNA
Former X CEO Yaccarino takes helm at digital health company eMed
Weight-loss focused digital company eMed Population Health on Tuesday named Linda Yaccarino, the former chief of Elon Musk's social media platform X, as CEO. The online weight management company's digital platform provides at-home diagnostics, proctor-led screenings and physician-guided prescribing for patients with obesity and type 2 diabetes. Yaccarino has virtually no experience in the health sector but brings more than a decade of advertising expertise. She led the modernization of NBCUniversal's ad business and built major brand partnerships at the Comcast-owned company. In her first public statement following her appointment, Yaccarino said, "There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before." At X, where she spent two years, Yaccarino was tasked with revitalizing the company's reputation among marketers who had fled the platform after its takeover by Musk. She stepped down from her role at the social media site in July, in a surprise move just months after the platform was acquired by the billionaire's AI startup, xAI.
